Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature
Jubb, E. Hasan, J. Cooper, Patricia A. Bibby, Michael C. Jayson, G.C. Pilarinou, E.
Jubb, E.
Hasan, J.
Cooper, Patricia A.
Bibby, Michael C.
Jayson, G.C.
Pilarinou, E.
Publication Date
2009-07-13
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Background: Previous studies have shown extensive vascularisation surrounding subcutaneously implanted fibres when the duration of the US National Cancer Institute (NCI) hollow fibre assay was prolonged. Materials and Methods: The feasibility of adapting the NCI assay for evaluating agents targeting the tumour vasculature was investigated in vitro and in vivo. Finally, in the optimised assay, changes in neovasculature formation around the fibres following treatment with the anti-vascular agent paclitaxel were quantified by immunohistochemistry. Results: Correlations between cell number seeded, time in culture and vascular endothelial growth factor (VEGF) secretion were seen. In vivo studies showed that transplanting single rather than 3 fibres at a site reduced inflammation, reducing the length of the fibre transplanted, as did without any significant loss in cell growth over 21 days. A statistically significant reduction in neovascularisation surrounding the fibres was seen accompanying paclitaxel treatment. Conclusion: Modifications made here to the NCI hollow fibre assay demonstrate its potential for analysing anti-tumour vasculature agents.
Version
No full-text in the repository
Citation
Shnyder SD, Hasan J, Jubb E et al. (2005) Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature. Anticancer Research. 25(3B): 1889-1894.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article